{'_id': 'chr7:g.140453134T>C', '_version': 4, 'cadd': {'_license': 'http://bit.ly/2TIuab9', 'alt': 'C', 'anc': 'T', 'annotype': 'CodingTranscript', 'bstatistic': 570, 'chmm': {'bivflnk': 0.0,'enh': 0.0, 'enhbiv': 0.0, 'het': 0.0, 'quies': 0.102, 'reprpc': 0.0, 'reprpcwk': 0.0, 'tssa': 0.0, 'tssaflnk': 0.0, 'tssbiv': 0.0, 'tx': 0.11, 'txflnk': 0.0, 'txwk': 0.78, 'znfrpts': 0.0}, 'chrom': 7, 'consdetail': 'missense', 'consequence': 'NON_SYNONYMOUS', 'consscore': 7, 'cpg': 0.01, 'dna': {'helt': -4.22, 'mgw': -0.11, 'prot': 4.19, 'roll': 0.29}, 'encode': {'exp': 21.94, 'h3k27ac': 6.0, 'h3k4me1': 17.72, 'h3k4me3': 4.08, 'nucleo': 1.6}, 'exon': '15/18', 'fitcons': 0.666978, 'gc': 0.4, 'gene': {'ccds_id': 'CCDS5863.1', 'cds': {'cdna_pos': 1862, 'cds_pos': 1801, 'rel_cdna_pos': 0.75, 'rel_cds_pos': 0.78}, 'feature_id': 'ENST00000288602', 'gene_id': 'ENSG00000157764', 'genename': 'BRAF', 'prot': {'domain': 'ndomain', 'protpos': 601, 'rel_prot_pos': 0.78}}, 'gerp': {'n': 5.65, 'rs': 771, 'rs_pval': 4.53805e-225, 's': 5.65}, 'grantham': 56, 'isderived': 'TRUE', 'isknownvariant': 'FALSE', 'istv': 'FALSE', 'length': 0, 'mapability': {'20bp': 1, '35bp': 1}, 'min_dist_tse': 18737, 'min_dist_tss': 878, 'mutindex': -5, 'naa': 'E', 'oaa': 'K', 'phast_cons': {'mammalian': 1.0, 'primate': 0.999, 'vertebrate': 1.0}, 'phred': 24.5, 'phylop': {'mammalian': 2.167, 'primate': 0.525, 'vertebrate': 5.101}, 'polyphen': {'cat': 'benign', 'val': 0.411}, 'pos': 140453134, 'rawscore': 4.669707, 'ref': 'T', 'segway': 'GE1', 'sift': {'cat': 'deleterious', 'val': 0}, 'type': 'SNV'}, 'chrom': '7', 'civic': {'_license': 'http://bit.ly/2FqS871', 'allele_registry_id': 'CA123645', 'civic_actionability_score': 3.0, 'clinvar_entries': '13966', 'coordinates': {'chromosome': '7', 'ensembl_version': 75, 'reference_bases': 'T', 'reference_build': 'GRCh37', 'representative_transcript': 'ENST00000288602.6', 'start': 140453134, 'stop': 140453134, 'variant_bases': 'C'}, 'entrez_id': 673, 'entrez_name': 'BRAF', 'evidence_items': [{'clinical_significance': 'Sensitivity/Response', 'description': 'The phase 2a MyPathway study assigned patients with HER2, EGFR, BRAF or SHH alterations to treatment with pertuzumab plus trastuzumab, erlotinib, vemurafenib, or vismodegib, respectively. Of 26 patients with BRAF V600E mutations, objective responses were seen in 12 patients (46%; 95% CI, 27% to 67%). Only one of 23 patients (4%; 95% CI, 0% to 22%) with other non-V600 BRAF mutations had a PR (pancreas cancer with a CUX1-BRAF fusion). Non-responding BRAF mutations included: K601E (n = 6), G464V (n = 2), G469A (n = 2), G496A (n = 2), N581S (n = 2), and one each for G466V, G596R, G606E, L597Q, P731T, intron 9 rearrangement, intron 10 rearrangement, and MACF1- and WASFL-BRAF fusion.', 'disease': {'display_name': 'Cancer', 'doid': 'DOID:162', 'id': 216, 'name': 'Cancer', 'url': 'http://www.disease-ontology.org/?id=DOID:162'}, 'drugs': [{'id': 4, 'name': 'Vemurafenib'}], 'evidence_direction': 'Does Not Support', 'evidence_level': 'B', 'evidence_type': 'Predictive', 'id': 5963, 'name': 'EID5963', 'open_change_count': 0, 'rating': 3, 'source': {'citation': 'Hainsworth et al., 2018, J. Clin. Oncol.', 'clinical_trials': [{'clinical_trial_url': 'https://clinicaltrials.gov/show/NCT02091141', 'description': "This multicenter, non-randomized, open-label study will evaluate the efficacy and safety of six treatment regimens in participants with advanced solid tumors for whom therapies that will convey clinical benefit are not available and/or are not suitable options per the treating physician's judgment.", 'name': 'My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors', 'nct_id': 'NCT02091141'}], 'full_journal_title': 'Journal of clinical oncology : official journal of the American Society of Clinical Oncology', 'id': 2414, 'is_review': False, 'journal': 'J. Clin. Oncol.', 'name': 'Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.', 'publication_date': {'day': 10, 'month': 1, 'year': 2018}, 'pubmed': 29320312, 'source_url': 'http://www.ncbi.nlm.nih.gov/pubmed/29320312', 'status': 'fully curated'}, 'status': 'submitted', 'type': 'evidence', 'variant_id': 584, 'variant_origin': 'Somatic Mutation'}, {'clinical_significance': 'Sensitivity/Response', 'description': 'In a study of 197 metastatic melanoma patients, BRAF mutations were identified in 95 patients including V600E (n=70), V600K (n=19), K601E (n=1) and D594N (n=1). Patients were treated with a specific RAF inhibitor (dabrafenib), which improved overall survival of patients with BRAF mutations (P<0.003), compared to non-treated patients with BRAF mutations. Patients having BRAF mutations without RAF inhibitor treatment were associated with reduced overall survival (11.1 mo vs. 46.1 mo for wild-type, P=0.006).', 'disease': {'display_name': 'Skin Melanoma', 'doid': 'DOID:8923', 'id': 206, 'name': 'Skin Melanoma', 'url': 'http://www.disease-ontology.org/?id=DOID:8923'}, 'drugs': [{'id': 22, 'name': 'Dabrafenib'}], 'evidence_direction': 'Supports', 'evidence_level': 'B', 'evidence_type': 'Predictive', 'id': 2812, 'name': 'EID2812', 'open_change_count': 0, 'source': {'citation': 'Long et al., 2011, J. Clin. Oncol.', 'full_journal_title': 'Journal of clinical oncology : official journal of the American Society of Clinical Oncology', 'id': 1488, 'is_review': False, 'journal': 'J. Clin. Oncol.', 'name': 'Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma.', 'publication_date': {'day': 1, 'month': 4, 'year': 2011}, 'pubmed': 21343559, 'source_url': 'http://www.ncbi.nlm.nih.gov/pubmed/21343559', 'status': 'fully curated'}, 'status': 'submitted', 'type': 'evidence', 'variant_id': 584, 'variant_origin': 'Somatic Mutation'}, {'clinical_significance': 'Sensitivity/Response', 'description': 'Preclinical study in 293H cell line. Ectopic expression of V600E, L597R/Q/S, and K601E mutants elevated phospho-MEK and ERK levels. Vemurafenib treatment of all of the BRAF mutant–expressing cells led to a decrease in phospho-MEK and ERK protein levels. Treatment with MEK inhibitor GSK1120212 led to a more dramatic decrease in phospho-ERK signaling.', 'disease': {'display_name': 'Skin Melanoma', 'doid': 'DOID:8923', 'id': 206, 'name': 'Skin Melanoma', 'url': 'http://www.disease-ontology.org/?id=DOID:8923'}, 'drug_interaction_type': 'Substitutes', 'drugs': [{'id': 19, 'name': 'Trametinib'}, {'id': 4, 'name': 'Vemurafenib'}], 'evidence_direction': 'Supports', 'evidence_level': 'D', 'evidence_type': 'Predictive', 'id': 1462, 'name': 'EID1462', 'open_change_count': 0, 'rating': 3, 'source': {'citation': 'Dahlman et al., 2012, Cancer Discov', 'full_journal_title': 'Cancer discovery', 'id': 338, 'is_review': False, 'journal': 'Cancer Discov', 'name': 'BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.', 'open_access': True, 'pmc_id': 'PMC3449158', 'publication_date': {'month': 9, 'year': 2012}, 'pubmed': 22798288, 'source_url': 'http://www.ncbi.nlm.nih.gov/pubmed/22798288', 'status': 'fullycurated'}, 'status': 'accepted', 'type': 'evidence', 'variant_id': 584, 'variant_origin': 'Somatic Mutation'}], 'gene_id': 5, 'hgvs_expressions': ['NM_004333.4:c.1801A>G', 'NP_004324.2:p.Lys601Glu', 'NC_000007.13:g.140453134T>C', 'ENST00000288602.6:c.1801A>G'], 'lifecycle_actions': {'last_commented_on': {'timestamp': '2017-07-25T21:06:17.016Z', 'user': {'area_of_expertise': 'Research Scientist', 'avatar_url': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=32', 'avatars': {'x128': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=128', 'x14': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=14', 'x32': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=32', 'x64': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=64'}, 'created_at': '2016-07-06T14:48:11.341Z', 'display_name': 'ebarnell', 'featured_expert': False, 'id': 179, 'last_seen_at': '2019-03-30T11:58:43.269Z', 'linkedin_profile': 'https://www.linkedin.com/in/erica-barnell-72b16a60', 'name': 'Erica Barnell', 'orcid': '0000-0003-1631-1201', 'organization': {'description': 'The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goalof understanding human health and disease, as well as evolution and the biology of other organisms.', 'id': 1, 'name': 'The McDonnell Genome Institute', 'profile_image': {'x128': '/system/organizations/profile_images/000/000/001/x128/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976','x14': '/system/organizations/profile_images/000/000/001/x14/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x256': '/system/organizations/profile_images/000/000/001/x256/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x32': '/system/organizations/profile_images/000/000/001/x32/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x64': '/system/organizations/profile_images/000/000/001/x64/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976'}, 'url': 'http://genome.wustl.edu/'}, 'role': 'admin', 'username': 'ebarnell'}}, 'last_modified': {'timestamp': '2017-06-11T03:17:04.220Z', 'user': {'area_of_expertise': 'Research Scientist', 'avatar_url': 'https://secure.gravatar.com/avatar/df7a6c4023eebf61d7bd8056368798c0.png?d=identicon&r=pg&s=32', 'avatars': {'x128': 'https://secure.gravatar.com/avatar/df7a6c4023eebf61d7bd8056368798c0.png?d=identicon&r=pg&s=128', 'x14': 'https://secure.gravatar.com/avatar/df7a6c4023eebf61d7bd8056368798c0.png?d=identicon&r=pg&s=14', 'x32': 'https://secure.gravatar.com/avatar/df7a6c4023eebf61d7bd8056368798c0.png?d=identicon&r=pg&s=32', 'x64': 'https://secure.gravatar.com/avatar/df7a6c4023eebf61d7bd8056368798c0.png?d=identicon&r=pg&s=64'}, 'created_at': '2015-10-05T13:05:07.668Z', 'display_name': 'LynzeyK', 'featured_expert': False, 'id': 83, 'last_seen_at': '2019-03-31T21:32:05.991Z','linkedin_profile': 'https://www.linkedin.com/in/lynzey-kujan-135a03a3', 'name': 'Lynzey Kujan', 'orcid': 'orcid.org/0000-0001-9225-7361', 'organization': {'description': 'The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches to the study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.', 'id': 1, 'name': 'TheMcDonnell Genome Institute', 'profile_image': {'x128': '/system/organizations/profile_images/000/000/001/x128/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x14': '/system/organizations/profile_images/000/000/001/x14/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x256': '/system/organizations/profile_images/000/000/001/x256/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x32': '/system/organizations/profile_images/000/000/001/x32/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x64': '/system/organizations/profile_images/000/000/001/x64/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976'}, 'url': 'http://genome.wustl.edu/'}, 'role': 'curator', 'username': 'LynzeyK'}}, 'last_reviewed': {'timestamp': '2017-07-25T21:06:17.016Z', 'user': {'area_of_expertise': 'Research Scientist', 'avatar_url': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=32', 'avatars': {'x128': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=128', 'x14': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=14', 'x32': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=32', 'x64': 'https://secure.gravatar.com/avatar/b9800d871c67538acd31728e8f509c80.png?d=identicon&r=pg&s=64'}, 'created_at': '2016-07-06T14:48:11.341Z', 'display_name': 'ebarnell', 'featured_expert': False, 'id': 179, 'last_seen_at': '2019-03-30T11:58:43.269Z', 'linkedin_profile': 'https://www.linkedin.com/in/erica-barnell-72b16a60', 'name': 'Erica Barnell', 'orcid': '0000-0003-1631-1201', 'organization': {'description': 'The McDonnell Genome Institute (MGI) is a world leader in the fast-paced, constantly changing field of genomics. A truly unique institution, we are pushing the limits of academic research by creating, testing, and implementing new approaches tothe study of biology with the goal of understanding human health and disease, as well as evolution and the biology of other organisms.', 'id': 1, 'name': 'The McDonnell Genome Institute', 'profile_image': {'x128': '/system/organizations/profile_images/000/000/001/x128/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x14': '/system/organizations/profile_images/000/000/001/x14/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x256': '/system/organizations/profile_images/000/000/001/x256/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x32': '/system/organizations/profile_images/000/000/001/x32/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976', 'x64': '/system/organizations/profile_images/000/000/001/x64/MGI_STANDARD4_logo_brown-example_v1b.png?1494525976'}, 'url': 'http://genome.wustl.edu/'}, 'role': 'admin', 'username': 'ebarnell'}}}, 'name': 'K601E', 'type': 'variant', 'variant_aliases': ['LYS601GLU', 'RS121913364'], 'variant_id': 584, 'variant_types': {'description': 'A sequence variant, that changes one or more bases,resulting in a different amino acid sequence but where the length is preserved.', 'display_name': 'Missense Variant', 'id': 47, 'name': 'missense_variant', 'so_id': 'SO:0001583', 'url': 'http://www.sequenceontology.org/browser/current_svn/term/SO:0001583'}}, 'clinvar': {'_license': 'http://bit.ly/2SQdcI0', 'allele_id': 29005, 'alt': 'C', 'chrom': '7', 'cytogenic': '7q34', 'gene': {'id': '673', 'symbol': 'BRAF'}, 'hg19': {'end': 140453134, 'start': 140453134}, 'hg38': {'end':140753334, 'start': 140753334}, 'hgvs': {'coding': ['LRG_299t1:c.1801A>G', 'NM_004333.5:c.1801A>G'], 'genomic': ['LRG_299:g.176431A>G', 'NC_000007.13:g.140453134T>C', 'NC_000007.14:g.140753334T>C', 'NG_007873.3:g.176431A>G']}, 'omim': '164757.0005', 'rcv': [{'accession': 'RCV000014999','clinical_significance': 'Pathogenic', 'conditions': {'identifiers': {'medgen': 'C0699790', 'omim': '114500'}, 'name': 'Carcinoma of colon (CRC)', 'synonyms': ['Colonic carcinoma', 'Colorectal cancer', 'Colorectal cancer, somatic', 'Colon cancer, somatic', 'Rectal cancer, somatic', 'Colon cancer']}, 'last_evaluated': '2005-09-01', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000015000', 'clinical_significance': 'Pathogenic', 'conditions':{'identifiers': {'human_phenotype_ontology': 'HP:0006731', 'medgen': 'C4225426', 'omim': '188470'}, 'name': 'Follicular thyroid carcinoma (NMTC2)', 'synonyms': ['Thyroid cancer, follicular', 'Thyroid carcinoma, follicular, somatic', 'THYROID CANCER, NONMEDULLARY, 2', 'THYROID CANCER, NONMEDULLARY, 2, SUSCEPTIBILITY TO']}, 'last_evaluated': '2005-09-01', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000037938', 'clinical_significance': 'Pathogenic', 'conditions': {'identifiers': {'human_phenotype_ontology': 'HP:0030358', 'medgen': 'C0007131', 'mesh': 'D002289'}, 'name': 'Non-small cell lung cancer (NSCLC)', 'synonyms': ['Non-small cell lung carcinoma']}, 'last_evaluated': '2011-08-23', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'criteria provided, single submitter'}, {'accession': 'RCV000422559', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'medgen': 'C0153574'}, 'name': 'Malignant neoplasm ofbody of uterus'}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000423181', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'medgen': 'C0278701'}, 'name': 'Adenocarcinoma of stomach'}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000425399', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'medgen': 'C0151779', 'mesh': 'C562393', 'omim': 'PS155600'}, 'name': 'Malignant melanoma of skin (CMM)', 'synonyms': ['MELANOMA, MALIGNANT, SOMATIC']}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000432202', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'human_phenotype_ontology': 'HP:0100031', 'medgen': 'C0040136', 'mesh': 'D013964'}, 'name': 'Neoplasm of the thyroid gland', 'synonyms': ['Neoplasia of the thyroid gland']}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000432849', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'medgen': 'C0007112'}, 'name': 'Adenocarcinoma of prostate'}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000433498', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'human_phenotype_ontology': 'HP:0030078', 'medgen': 'C0152013', 'mesh': 'C538231'}, 'name': 'Lung adenocarcinoma', 'synonyms': ['Adenocarcinoma of lung', 'Adenocarcinoma of lung, somatic']}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000440232', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'human_phenotype_ontology': 'HP:0006760', 'medgen': 'C0023434', 'mesh': 'D015451', 'omim': '151400', 'orphanet': '67038'}, 'name': 'Chronic lymphocytic leukemia (CLL)', 'synonyms': ['Chronic lymphatic leukemia', 'B-cell chronic lymphocytic leukemia']}, 'last_evaluated': '2016-05-31', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000440872', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'human_phenotype_ontology': 'HP:0012056', 'medgen': 'C0025202', 'mesh': 'D008545'}, 'name': 'Cutaneous melanoma', 'synonyms': ['Melanoma', 'Malignant melanoma, somatic']}, 'last_evaluated': '2015-07-14', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}, {'accession': 'RCV000443528', 'clinical_significance': 'Likely pathogenic', 'conditions': {'identifiers': {'human_phenotype_ontology': 'HP:0006741', 'medgen': 'C0027651', 'mesh': 'D009369'}, 'name': 'Neoplasm', 'synonyms': ['Cancer', 'Neoplasia', 'Oncological abnormality', 'Oncology', 'Tumor', 'Tumour']}, 'last_evaluated': '2016-05-13', 'number_submitters': 1, 'origin': 'somatic', 'preferred_name': 'NM_004333.5(BRAF):c.1801A>G (p.Lys601Glu)', 'review_status': 'no assertion criteria provided'}], 'ref': 'T', 'rsid': 'rs121913364', 'type': 'single nucleotide variant', 'variant_id': 13966}, 'cosmic': {'_license': 'http://bit.ly/2VMkY7R', 'alt': 'G', 'chrom':'7', 'cosmic_id': 'COSM478', 'hg19': {'end': 140453134, 'start': 140453134}, 'mut_freq': 0.07, 'mut_nt': 'A>G', 'ref': 'A', 'tumor_site': 'upper_aerodigestive_tract'}, 'dbnsfp': {'_license': 'http://bit.ly/2VLnQBz', 'aa': {'alt': 'E', 'codon_degeneracy': 0, 'codonpos': 1, 'pos': ['601','641', '601', '641'], 'ref': 'K', 'refcodon': 'AAA'}, 'aloft': {'confidence': ['.', '.', '.', '.'], 'pred': ['.', '.', '.', '.'], 'prob_dominant': ['.', '.', '.', '.'], 'prob_recessive': ['.', '.', '.', '.'], 'prob_tolerant': ['.', '.', '.', '.']}, 'alt': 'C', 'ancestral_allele': 'T', 'appris': ['alternative2', 'alternative2', 'principal2', 'alternative2'], 'bstatistic': {'rankscore': 0.53653, 'score': 789}, 'chrom': '7', 'clinvar': {'clinsig': 'Pathogenic', 'hgvs': 'NC_000007.14:g.140753334T>C', 'review': ['criteria_provided', '_single_submitter'], 'rs': 13966, 'trait': ['Chronic_lymphocytic_leukemia', 'Follicular_thyroid_carcinoma', 'Cutaneous_melanoma', 'Lung_adenocarcinoma', 'Non-small_cell_lung_cancer', 'Neoplasm_of_the_thyroid_gland', 'Malignant_melanoma_of_skin', 'Neoplasm', 'Adenocarcinoma_of_prostate', 'Malignant_neoplasm_of_body_of_uterus', 'Adenocarcinoma_of_stomach', 'Carcinoma_of_colon'], 'var_source': ['OMIM_Allelic_Variant:164757.0005', 'UniProtKB_(protein):P15056#VAR_018630']}, 'dann': {'rankscore': 0.95076, 'score': 0.9987331760955661}, 'deogen2': {'pred': ['.', '.', 'D', '.'], 'rankscore': 0.95477, 'score': [0.816905]}, 'eigen': {'phred_coding': 4.031274, 'raw_coding': 0.347008165968673, 'raw_coding_rankscore': 0.58582}, 'eigen-pc': {'phred_coding': 4.907832, 'raw_coding': 0.471305781262729, 'raw_rankscore': 0.66096}, 'ensembl': {'geneid': ['ENSG00000157764', 'ENSG00000157764', 'ENSG00000157764', 'ENSG00000157764'], 'proteinid': ['ENSP00000419060', 'ENSP00000496776', 'ENSP00000493543', 'ENSP00000288602'], 'transcriptid': ['ENST00000496384', 'ENST00000644969', 'ENST00000646891', 'ENST00000288602']}, 'fathmm-mkl': {'coding_group': 'AEFI', 'coding_pred': 'D', 'coding_rankscore': 0.76464, 'coding_score': 0.97694}, 'fathmm-xf': {'coding_pred': 'D', 'coding_rankscore': 0.84324, 'coding_score': 0.899162}, 'genecode_basic': ['Y', 'Y', 'Y', 'Y'], 'genename': 'BRAF', 'genocanyon': {'rankscore': 0.74766, 'score': 0.999999994558225}, 'gerp++': {'nr': 5.65, 'rs': 5.65, 'rs_rankscore': 0.86881}, 'gm12878': {'confidence_value': 0, 'fitcons_rankscore': 0.7944, 'fitcons_score': 0.708844}, 'h1-hesc': {'confidence_value': 0, 'fitcons_rankscore': 0.34648, 'fitcons_score': 0.602189}, 'hg18': {'end': 140099603, 'start': 140099603}, 'hg19': {'end': 140453134, 'start':140453134}, 'hg38': {'end': 140753334, 'start': 140753334}, 'huvec': {'confidence_value': 0, 'fitcons_rankscore': 0.65921, 'fitcons_score': 0.6691}, 'integrated': {'confidence_value': 0, 'fitcons_rankscore': 0.46895, 'fitcons_score': 0.6512}, 'interpro_domain': ['Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain', 'Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain', 'Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain', 'Serine-threonine/tyrosine-protein kinase, catalytic domain|Protein kinase domain|Protein kinase domain'], 'lrt': {'converted_rankscore': 0.8433, 'omega': 0.0, 'pred': 'D', 'score': 0.0}, 'm_cap_score': {'pred': 'D', 'rankscore': 0.73821, 'score': 0.082075}, 'metalr': {'pred': 'T','rankscore': 0.53571, 'score': 0.186}, 'metasvm': {'pred': 'T', 'rankscore': 0.50173, 'score': -0.8747}, 'mpc': {'rankscore': 0.91163, 'score': [1.76399393158]}, 'mutationassessor': {'pred': ['.', '.', 'L', '.'], 'rankscore': 0.21287, 'score': [0.855]}, 'mutationtaster': {'AAE': 'K601E', 'converted_rankscore': 0.81001, 'model': 'simple_aae', 'pred': 'D', 'score': 1}, 'mvp': {'rankscore': 0.98171, 'score': [0.981911468535]}, 'phastcons': {'100way': {'vertebrate': 1.0, 'vertebrate_rankscore': 0.71638}, '30way': {'mammalian': 1.0, 'mammalian_rankscore': 0.86279}, 'p17way': {'primate': 1.0, 'primate_rankscore': 0.97212}}, 'phylo': {'p100way': {'vertebrate': 7.942, 'vertebrate_rankscore': 0.87182}, 'p17way': {'primate': 0.66, 'primate_rankscore': 0.55035}, 'p30way': {'mammalian': 1.115, 'mammalian_rankscore': 0.55709}}, 'polyphen2': {'hdiv': {'pred': ['.','.', 'P', '.'], 'rankscore': 0.45825, 'score': [0.784]}, 'hvar': {'pred': ['.', '.', 'P', '.'],'rankscore': 0.53163, 'score': [0.626]}}, 'primateai': {'pred': 'D', 'rankscore': 0.92107, 'score': 0.866800785065}, 'provean': {'pred': ['.', '.', '.', '.']}, 'ref': 'T', 'reliability_index': 10, 'revel': {'rankscore': 0.97848, 'score': 0.916}, 'rsid': 'rs121913364', 'sift': {'pred': ['.', '.', '.', '.']}, 'sift4g': {'pred': ['.', '.', '.', '.']}, 'siphy_29way': {'logodds': 15.9326, 'logodds_rankscore': 0.79463, 'pi': {'a': 0.0, 'c': 0.0, 'g': 0.0, 't': 1.0}}, 'tsl': [5, 1], 'uniprot': [{'acc': 'H7C560', 'entry': 'H7C560_HUMAN'}, {'acc': 'A0A2R8Y8E0', 'entry': 'A0A2R8Y8E0_HUMAN'}, {'acc': 'P15056', 'entry': 'BRAF_HUMAN'}, {'acc': 'A0A2U3TZI2', 'entry': 'A0A2U3TZI2_HUMAN'}], 'vep_canonical': ['YES']}, 'dbsnp': {'_license': 'http://bit.ly/2AqoLOc', 'allele_origin': 'both', 'alleles': [{'allele': 'T'}, {'allele': 'C'}, {'allele': 'G'}], 'alt': 'C', 'chrom': '7', 'class': 'SNV', 'dbsnp_build': 133, 'flags': ['ASP', 'LSD', 'NSM', 'PM', 'PMC', 'REF','RV', 'S3D'], 'gene': {'geneid': '673', 'symbol': 'BRAF'}, 'hg19': {'end': 140453134, 'start': 140453134}, 'ref': 'T', 'rsid': 'rs121913364', 'validated': False, 'var_subtype': 'unknown', 'vartype': 'snp'}, 'docm': {'_license': '', 'aa_change': 'p.K601E', 'all_domains': 'pfam_Ser-Thr/Tyr_kinase_cat_dom,pfam_Prot_kinase_dom,pfam_Raf-like_ras-bd,pfam_Prot_Kinase_C-like_PE/DAG-bd,superfamily_Kinase-like_dom,smart_Raf-like_ras-bd,smart_Prot_Kinase_C-like_PE/DAG-bd,smart_Ser/Thr_dual-sp_kinase_dom,smart_Tyr_kinase_cat_dom,pfscan_Raf-like_ras-bd,pfscan_Prot_Kinase_C-like_PE/DAG-bd,pfscan_Prot_kinase_dom,prints_Ser-Thr/Tyr_kinase_cat_dom,prints_DAG/PE-bd', 'alt': 'C', 'c_position': 'c.1801', 'chrom': 7, 'default_gene_name': 'BRAF', 'deletion_substructures': '-', 'disease': 'Melanoma', 'doid': 'DOID:1909', 'domain': 'pfam_Ser-Thr/Tyr_kinase_cat_dom,pfam_Prot_kinase_dom,superfamily_Kinase-like_dom,smart_Ser/Thr_dual-sp_kinase_dom,smart_Tyr_kinase_cat_dom,pfscan_Prot_kinase_dom', 'ensembl_gene_id': 'ENSG00000157764', 'genename': 'BRAF', 'genename_source': 'HGNC', 'hg19': {'end': 140453134, 'start': 140453134}, 'primary': 1, 'pubmed_id': '14679157, 12068308, 22798288, 20818844, 21639808, 22356324, 22663011, 22663011, 22805292, 22048237, 22972589', 'ref': 'T', 'source': 'MyCancerGenome', 'strand': -1, 'transcript_error': 'no_errors','transcript_name': 'ENST00000288602', 'transcript_source': 'ensembl', 'transcript_species': 'human', 'transcript_status': 'known', 'transcript_version': '74_37', 'trv_type': 'missense', 'type': 'SNP', 'ucsc_cons': 1, 'url': 'http://www.mycancergenome.org/content/disease/melanoma/braf/190'}, 'gnomad_exome': {'ac': {'ac': 1, 'ac_afr': 0, 'ac_amr': 0, 'ac_asj': 0, 'ac_eas': 0, 'ac_female': 1, 'ac_fin': 0, 'ac_male': 0, 'ac_nfe': 1, 'ac_oth': 0, 'ac_popmax': 1, 'ac_raw': 2, 'ac_sas': 0}, 'af': {'af': 4.06488e-06, 'af_afr': 0.0, 'af_amr': 0.0, 'af_asj': 0.0, 'af_eas': 0.0, 'af_female': 8.98828e-06, 'af_fin': 0.0, 'af_male': 0.0, 'af_nfe': 8.96379e-06, 'af_oth': 0.0, 'af_popmax': 8.96379e-06, 'af_raw': 8.12117e-06, 'af_sas': 0.0}, 'alleles': 'C', 'alt': 'C', 'an': {'an': 246010, 'an_afr': 15300, 'an_amr': 33514, 'an_asj': 9848, 'an_eas': 17248, 'an_female':111256, 'an_fin': 22288, 'an_male': 134754, 'an_nfe': 111560, 'an_oth': 5472, 'an_popmax': 111560, 'an_raw': 246270, 'an_sas': 30780}, 'baseqranksum': 2.39, 'chrom': '7', 'clippingranksum': 0.416, 'filter': 'RF', 'fs': 1.72, 'gc': {'gc': [123004, 1, 0], 'gc_afr': [7650, 0, 0], 'gc_amr':[16757, 0, 0], 'gc_asj': [4924, 0, 0], 'gc_eas': [8624, 0, 0], 'gc_female': [55627, 1, 0], 'gc_fin': [11144, 0, 0], 'gc_male': [67377, 0, 0], 'gc_nfe': [55779, 1, 0], 'gc_oth': [2736, 0, 0], 'gc_raw': [123133, 2, 0], 'gc_sas': [15390, 0, 0]}, 'hom': {'hom': 0, 'hom_afr': 0, 'hom_amr': 0, 'hom_asj': 0, 'hom_eas': 0, 'hom_female': 0, 'hom_fin': 0, 'hom_male': 0, 'hom_nfe': 0, 'hom_oth': 0, 'hom_raw': 0, 'hom_sas': 0}, 'inbreedingcoeff': 0.0001, 'mq': {'mq': 59.66, 'mqranksum':0.43}, 'pos': 140453134, 'qd': 12.42, 'readposranksum': 0.982, 'ref': 'T', 'rsid': 'rs121913364', 'type': 'snp', 'vqslod': 1.95, 'vqsr_culprit': 'FS'}, 'hg19': {'end': 140453134, 'start': 140453134}, 'mutdb': {'_license': 'http://bit.ly/2SQ6fXA', 'alt': 'G', 'chrom': '7', 'cosmic_id': '13982, 478', 'hg19': {'end': 140453134, 'start': 140453134}, 'mutpred_score': 0.684, 'ref': 'A','rsid': 'rs121913364', 'strand': 'm', 'uniprot_id': 'VAR_018630'}, 'observed': True, 'snpeff': {'_license': 'http://bit.ly/2suyRKt', 'ann': [{'effect': 'protein_protein_contact', 'feature_id': '4MNE:D_320-F_601:NM_002755.3-NM_004333.4', 'feature_type': 'interaction', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'putative_impact': 'HIGH', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}, {'effect': 'structural_interaction_variant', 'feature_id': '4E26:A_571-A_601:NM_004333.4', 'feature_type': 'interaction', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'putative_impact': 'HIGH', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}, {'effect': 'structural_interaction_variant', 'feature_id': '4MNE:C_571-C_601:NM_004333.4', 'feature_type': 'interaction', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'putative_impact': 'HIGH', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}, {'effect': 'structural_interaction_variant', 'feature_id': '4MNE:G_571-G_601:NM_004333.4', 'feature_type': 'interaction', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'putative_impact': 'HIGH', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}, {'effect': 'structural_interaction_variant', 'feature_id': '4WO5:A_574-A_601:NM_004333.4', 'feature_type': 'interaction', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'putative_impact': 'HIGH', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}, {'effect': 'structural_interaction_variant', 'feature_id': '4WO5:A_576-A_601:NM_004333.4', 'feature_type': 'interaction', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'putative_impact': 'HIGH', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}, {'cdna': {'length': '2946', 'position': '1862'}, 'cds': {'length': '2301', 'position': '1801'}, 'effect': 'missense_variant', 'feature_id': 'NM_004333.4', 'feature_type': 'transcript', 'gene_id': 'BRAF', 'genename': 'BRAF', 'hgvs_c': 'c.1801A>G', 'hgvs_p': 'p.Lys601Glu', 'protein': {'length': '766', 'position': '601'}, 'putative_impact': 'MODERATE', 'rank': '15', 'total': '18', 'transcript_biotype': 'protein_coding'}]}, 'vcf': {'alt': 'C', 'position': '140453134', 'ref': 'T'}}